TWiV 874: COVID-19 clinical update #105 with Dr. Daniel Griffin
About this episode
In COVID-19 clinical update #105, Daniel Griffin discusses changes in brain structure after infection, dementia in patients with pneumonia, Paxlovid in children, mask effectiveness in schools, host factors and severe disease, post-acute symptoms, and the mission of CEPI.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Infection and changes in brain structure (Nature)
- Dementia among pneumonia survivors (Open Forum Inf Dis)
- Narrative dynamics around COVID-19 vaccines (FSI)
- Children and COVID (AAP)
- Paxlovid in pediatric patients (Pfizer)
- Mask effectiveness in schools (MMWR)
- Host factors and severe disease (Nature)
- Antiviral efficacy against BA.2 (NEJM)
- Post-acute symptoms, Denmark (medRxiv)
- Risk of sequelae after infection (BMJ)
- CEPI (TWiV 612)
- Contribute to ASTMH fundraiser at PWB
- Letters read on TWiV 874
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to [email protected]
Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Virology
TWiV 1309: Maybe they're all cancer vaccines
This Week in Virology
TWiV 1308: Clinical update with Dr. Daniel Griffin
This Week in Virology
TWiV 1307: My heart breaks for flu
This Week in Virology
TWiV 1306: Clinical update with Dr. Daniel Griffin
This Week in Virology